Ficlatuzumab can be used to treat head and neck squamous cell carcinoma (HNSCC) by inhibiting c-Met receptor-mediated cell proliferation, migration, and invasion.
To understand the effect of ficlatuzumab on HNSCC proliferation, migration, and invasion.
Design, Setting, and Participants
The effects of ficlatuzumab on ...
JAMA Otolaryngol Head Neck Surg. Published online November 05, 2015. doi:10.1001/jamaoto.2015.2381